No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy

被引：14
|
作者：
Yamada, M
Sodeyama, N
Itoh, Y
Otomo, E
Matsushita, M
Mizusawa, H
机构：
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa 920, Japan
[2] Tokyo Inst Psychiat, Dept Neuropathol, Tokyo, Japan
[3] Yokufukai Geriatr Hosp, Dept Pathol, Tokyo, Japan
[4] Yokufukai Geriatr Hosp, Dept Internal Med, Tokyo, Japan
[5] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Neurol, Tokyo, Japan
来源：
STROKE | 2002年 / 33卷 / 04期
关键词：
Alzheimer disease; amyloid; atherosclerosis; cerebrovascular disorders; polymorphism (genetics);
D O I：
10.1161/01.STR.0000013673.70986.AB
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Background and Purpose-Both cerebral amyloid angiopathy (CAA) and paraoxonase have been reported to be related to lipid metabolism and atherosclerosis. We investigated whether the paraoxonase gene (PON1) polymorphism and atherosclerosis are associated with risk of CAA. Methods-Associations of the PON1 polymorphism and atherosclerosis of the aorta and coronary and cerebral arteries with the severity of CAA were investigated in 154 elderly Japanese individuals, including 47 patients with Alzheimer's disease. Results-The PON1 polymorphism or severity of atherosclerosis of the arteries was not associated with the severity of CAA. Conclusions-The PON1 polymorphism and atherosclerosis would not appear to be associated with risk of CAA in the,elderly, although further study with larger samples is necessary for confirmation.
引用
收藏
页码：896 / 900
页数：5
相关论文
共 50 条
  • [31] CEREBRAL AMYLOID ANGIOPATHY
    CLARK, WC
    ROBERTSON, JH
    SOUTHERN MEDICAL JOURNAL, 1986, 79 (09) : 29 - 29
  • [32] CEREBRAL AMYLOID ANGIOPATHY
    VANLEY, CT
    AGUILAR, MJ
    KLEINHENZ, RJ
    LAGIOS, MD
    HUMAN PATHOLOGY, 1981, 12 (07) : 609 - 616
  • [33] Cerebral Amyloid Angiopathy
    Tzimou, M.
    Anastasiou, A.
    Katsarou, Z.
    Pyrpasopoulou, A.
    Douma, S.
    NEURORADIOLOGY JOURNAL, 2012, 25 (05): : 525 - 527
  • [34] Cerebral amyloid angiopathy
    Rosand, J
    Greenberg, SM
    NEUROLOGIST, 2000, 6 (06) : 315 - 325
  • [35] Cerebral amyloid angiopathy
    Weller, RO
    BRAIN PATHOLOGY, 2000, 10 (04) : 591 - 591
  • [36] Apolipoprotein E genotype predicts hemorrhage recurrence in cerebral amyloid angiopathy
    O'Donnell, HC
    Rosand, J
    Chiu, RI
    Furie, KL
    Ikeda, D
    Greenberg, SM
    STROKE, 1999, 30 (01) : 255 - 255
  • [37] Cerebral Amyloid Angiopathy
    Szidonya, Laszlo
    Nickerson, Joshua P.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2023, 61 (03) : 551 - 562
  • [38] Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage
    McCarron, MO
    Nicoll, JAR
    VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 : 176 - 179
  • [39] Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal
    McCarter, Stuart J.
    Lesnick, Timothy G.
    Lowe, Val
    Mielke, Michelle M.
    Constantopoulos, Eleni
    Rabinstein, Alejandro A.
    Przybelski, Scott A.
    Botha, Hugo
    Jones, David T.
    Ramanan, Vijay K.
    Jack, Clifford R.
    Petersen, Ronald C.
    Knopman, David
    Boeve, Bradley F.
    Murray, Melissa E.
    Dickson, Dennis W.
    Vemuri, Prashanthi
    Kantarci, Kejal
    Reichard, R. Ross
    Graff-Radford, Jonathan
    NEUROLOGY, 2021, 97 (18) : E1799 - E1808
  • [40] Association of apolipoprotein E ε2 and vasculopathy in cerebral amyloid angiopathy
    Greenberg, SM
    Vonsattel, JPG
    Segal, AZ
    Chiu, RI
    Clatworthy, AE
    Liao, A
    Hyman, BT
    Rebeck, GW
    NEUROLOGY, 1998, 50 (04) : 961 - 965
12345